In the second in a series of three podcasts, C+D speaks with Dr Elizabeth Angier, a portfolio GP with an interest in allergy. Dr Angier works across...
GSK will have a 68% stake in the joint venture, which will bring its Sensodyne, Voltaren and Panadol brands and Pfizer’s Advil, Centrum and Caltrate...
The shortage means patients looking for the vaccination will “often have to visit more than one establishment”, or “may be advised to delay...
Sensodyne Rapid Relief – “designed to provide fast relief from sensitivity pain” – launched in both original and whitening varieties on June 3. The...
Voltarol manufacturer GSK partnered with the Mayor of London to fund the ‘Get Moving’ project, which ran in 2016 and promoted the health benefits of...
Download the C+D app today for free on your iOS or Android phone or tablet. Access the latest and most popular news.
SIGN UP FOR OUR NEWSLETTERS
- C+D Daily Bulletin
- • C+D CPD Bulletin
- • C+D Saturday Review
- • C+D Careers Bulletin
- • C+D Briefing Newsletter